Development asset linked to Protagonist Therapeutics in public FDA and regional records.
pharma · Polycythemia Vera · Ulcerative Colitis Chronic Moderate · PTGX
Protagonist Therapeutics
Protagonist Therapeutics, Inc
Protagonist Therapeutics drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
7707 Gateway Blvd, Suite 140, Newark, California 94560, US HQ
2006 Founded
153 Employees
Public company Type
PTGX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 7707 Gateway Blvd, Suite 140, Newark, California 94560, US
- Founded
- 2006
- Employees
- 153
- Programs
- 13
- Drugs
- 5
- Patents
- 33
Protagonist Therapeutics pipeline
Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Protagonist Therapeutics drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Protagonist Therapeutics in public FDA and regional records.
-
Development asset linked to Protagonist Therapeutics in public FDA and regional records.
-
Development asset linked to Protagonist Therapeutics in public FDA and regional records.
-
Development asset linked to Protagonist Therapeutics in public FDA and regional records.